1 1

HealthCert Education

Medicinal Cannabis - PTSD – Treatment in clinical practice

Medicinal Cannabis - PTSD – Treatment in clinical practice

The "Medicinal Cannabis - PTSD Treatment in Clinical Practice" course equips healthcare professionals with a comprehensive understanding of how medicinal cannabis can be integrated into PTSD treatment plans. This evidence-based course examines PTSD's complex symptoms, conventional treatments, and the emerging role of cannabinoids, supported by research and real-world case studies. Participants will learn about treatment protocols, dosing strategies, patient assessments, and the practicalities of prescribing medicinal cannabis. Designed to enhance clinical skills and patient outcomes, the course is a vital resource for practitioners exploring innovative therapies for PTSD.

time-icon 4.0 hrs EA | 6.0 hrs RP | 0.0 hrs OM
$195.00
$195.00
Sale Sold out

SHOP-D3CBD

View full details

  • FLEXIBLE TIMING

  • 100% ONLINE

  • accredited Course

  • Expert instructor

The "Medicinal Cannabis - PTSD: Treatment in Clinical Practice" course offers an in-depth understanding of PTSD and its treatment with medicinal cannabis. Led by experienced clinician Dr. John Tay, this program provides the tools and knowledge required to incorporate cannabinoid therapies into PTSD management effectively.

Unit 1 introduces PTSD, covering its symptoms, diagnostic criteria, and underlying neurobiology. Participants learn how traumatic events trigger physiological responses, including hypervigilance, avoidance, emotional dysregulation, and memory alterations. The unit establishes a foundation for understanding the role of the endocannabinoid system in PTSD and its potential therapeutic implications.

Unit 2 focuses on treatment approaches, comparing conventional options such as SSRIs, antipsychotics, and psychotherapy with medicinal cannabis therapies. The unit explains how cannabinoids like CBD and THC interact with the endocannabinoid system to reduce anxiety, regulate emotions, and facilitate fear extinction. Detailed dosing strategies for oral, sublingual, and inhaled cannabis are provided, emphasising personalised care.

Unit 3 explores the regulatory landscape for medicinal cannabis in PTSD treatment, particularly in Australia. It discusses the policies of the Department of Veterans Affairs (DVA) and offers guidance on securing funding for veterans with chronic pain or PTSD-related symptoms. Participants learn to navigate legal and bureaucratic processes to support their patients.

Unit 4 uses case studies to illustrate the practical application of cannabinoid therapies. Two detailed cases highlight tailored treatment plans for veterans with PTSD, demonstrating how individualised dosing and cannabinoid selection can address symptoms like anxiety, hypervigilance, insomnia, and pain. These real-world examples underscore the importance of titrating treatments to patient needs while considering co-morbidities and prior cannabis use.

This course equips healthcare professionals with the knowledge to integrate medicinal cannabis into PTSD treatment safely and effectively, ensuring improved patient outcomes and advancing clinical practice in this evolving field.

Assess the use of medicinal cannabis for PTSD, including dosage and treatment in clinical practice

This course is designed for GPs and is also suitable for all degree qualified medical professionals.

cpd hours image

CPD Hours:

  • Education hours:  4.0
  • Reviewing performance hours: 6.0
  • Measuring outcome hours:  0.0
cpd hours image

Accreditations:

Royal Australian College of General Practice (RACGP) #434272

Australian College of Rural and Remote Medicine (ACRRM) #30987

cpd hours image

Study Mode:

100% online

cpd hours image

Study duration:

10.0 hrs self-paced

cpd hours image

ABOUT THE PRESENTER

Dr John Teh

This course is presented by Dr John Teh MBBS.

John is the Medical Director of Plantmed Medical Cannabis Clinic, Australia. He has been working within the Medicinal Cannabis industry since the legalisation of cannabis for medicinal use in Australia in February 2016. Dr Teh is actively involved in Cannabis Medicine education, training medical practitioners and allied health professionals in all areas of cannabinoid therapeutics. He is a medical advisor to various cannabis producers and suppliers within Australia, and consulted the Thailand government prior to the introduction of their medicinal cannabis program in 2019. Dr Teh has vast experience treating a variety of patients with Medical Cannabis and integrates nutrition and plant based medicines which support cannabinoid treatment in his practice. His wealth of knowledge makes him sought after in all areas of cannabis medicine and education.